-
Palantir, Moderna, Pfizer, Alibaba, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Thursday, November 14, 2024 - 10:16pm | 650The US stock market experienced a downward trend on Thursday, with both the Nasdaq Composite and the S&P 500 indices falling by nearly 0.6% respectively. The Dow also traded down by 0.5% to 43,750.86. This came amidst news of a 0.2% rise in U.S. producer prices for October. Federal Reserve...
-
Intel, Microsoft, Meta Platforms, Pfizer, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Monday, September 16, 2024 - 10:50pm | 564On Monday, major U.S. indices showed mixed results. The Dow Jones Industrial Average closed 0.5% higher at 41,622.08, while the S&P 500 edged up 0.1% to 5,633.09. Meanwhile, the Nasdaq fell by 0.5%, closing at 17,592.13. These are the top stocks that gained the attention of retail traders and...
-
Late-Stage Vaccine Trials From Pfizer, Moderna May Have Encouraged Investors
Tuesday, July 28, 2020 - 10:10am | 1815(Tuesday Market Open) As earnings season shifts into a higher gear during this busy week, investors not only have quarterly corporate performance on their mind but also the congressional debate about another round of stimulus and a Fed meeting where market participants are likely hoping to hear...
-
Pfizer Inc. Trying To Claw Its Way Back Up After Pullback
Wednesday, September 10, 2014 - 10:33am | 460Pfizer Inc. (NYSE: PFE) stock has bounced off the August lows and is now working to challenge the short-term downtrend line resistance at around $30. Do the company's fundamentals call for higher prices? Pfizer shareholders, like so many in the big pharma sector, long for the days of...
-
Citi Raises PT On PFE To $23
Wednesday, April 13, 2011 - 8:09am | 116Citi has raised its price target on Pfizer (NYSE: PFE) from $20 to $23 and maintains its Hold rating based upon meeting with the company's president and CEO Ian Read to discuss strategy execution. In the report, Citi writes, “We look for Read to 1) divest no-growth/low return/non- core assets, 2)...